Women's Health
What Happens to LH Levels with PCOS?
In polycystic ovary syndrome, LH is one of the most consistently disrupted hormones — yet it rarely appears on standard hormone panels. Elevated LH drives excess androgen production, suppresses ovulation, and sits at the center of the hormonal cascade that defines PCOS. Understanding what it does — and why it's elevated — is a prerequisite to actually addressing the condition.
What Happens to LH Levels with PCOS?
In most women with PCOS, LH (luteinizing hormone) is chronically elevated — often two to three times higher than FSH — and this ratio inversion is a defining feature of the syndrome. Elevated LH signals the ovaries to overproduce androgens without triggering proper ovulation. The main caveat: not every woman with PCOS has a visibly high LH, especially in obesity-dominant phenotypes where the signal is blunted. Women who are lean with irregular cycles are most likely to show the classic LH surge pattern.
---
What LH Actually Does in a Healthy Cycle
Luteinizing hormone is secreted by the anterior pituitary gland in response to gonadotropin-releasing hormone (GnRH) pulses from the hypothalamus. In a healthy cycle, LH remains relatively low during the follicular phase, surges sharply at mid-cycle to trigger ovulation, and then recedes during the luteal phase. Follicle-stimulating hormone (FSH) rises early in the cycle to mature follicles, and the two hormones work in coordination.
The ratio of LH to FSH at the start of a cycle is normally close to 1:1. When this ratio exceeds 2:1 or 3:1, it suggests the hypothalamic-pituitary axis is pulsing GnRH too rapidly, favoring LH secretion over FSH. That shift has downstream consequences for every reproductive hormone in the chain.
---
How PCOS Disrupts LH: The Pulse Frequency Problem
The central mechanism driving elevated LH in PCOS is increased GnRH pulse frequency from the hypothalamus. Research published in the New England Journal of Medicine established that women with PCOS have faster GnRH pulse rates compared to women with normal cycles — these rapid pulses selectively amplify LH release while blunting FSH (Rebar et al., NEJM 1976; PMID: 766827). More recent work confirmed that this accelerated pulsatility is at least partly driven by a loss of progesterone's normal slowing effect on the GnRH pulse generator — meaning the luteal phase feedback loop is broken (McCartney et al., Journal of Clinical Endocrinology & Metabolism 2002; PMID: 12364417).
The elevated LH then acts on theca cells in the ovarian follicle, stimulating them to produce androgens — primarily androstenedione and testosterone. Without a corresponding FSH rise to convert those androgens to estrogen and mature follicles appropriately, follicular development stalls. Multiple small follicles accumulate but never reach ovulatory size. This is the mechanism that produces both the polycystic ovary appearance on ultrasound and the clinical symptoms of androgen excess.
For a detailed look at how free testosterone behaves in this context, see what happens to free testosterone with PCOS.
---
The LH:FSH Ratio — What the Numbers Mean
| LH:FSH Ratio | Interpretation |
|---|---|
| 1:1 | Normal early follicular pattern |
| 2:1 | Borderline; worth monitoring with symptoms |
| ≥ 3:1 | Strongly associated with PCOS phenotype |
| Very high LH with low/normal FSH | Classic lean PCOS pattern |
| Normal or low LH | More common in obese PCOS; not a rule-out |
It's worth noting that a single LH measurement is not diagnostic on its own — LH pulses roughly every 60 to 90 minutes in healthy women, and the pulsatility is even more erratic in PCOS. A result drawn at the wrong moment can appear falsely low or falsely high. Clinicians often request LH on day 3 of the cycle alongside FSH and estradiol to get a meaningful snapshot.
Insulin resistance compounds the LH problem in a separate pathway. Elevated insulin independently stimulates theca cell androgen production and may suppress sex hormone-binding globulin (SHBG), leaving more free testosterone in circulation. This is why fasting insulin is such a relevant marker in PCOS — it is not just a metabolic issue; it directly feeds the androgen excess that LH alone drives.
---
Why Some Women with PCOS Have Normal LH
This confuses a lot of people who receive a PCOS diagnosis but have an LH reading within the reference range. Several factors suppress LH even when the underlying condition is present:
- Obesity: Adipose tissue converts androgens to estrogens, and higher circulating estrogen dampens LH secretion through negative feedback. Studies show that obese women with PCOS have significantly lower LH levels than lean women with PCOS despite similar androgen profiles (Morales et al., Journal of Clinical Endocrinology & Metabolism 1996; PMID: 8772579).
- Oral contraceptive use: Combined oral contraceptives powerfully suppress GnRH pulsatility. LH may remain suppressed for weeks after stopping the pill, obscuring the PCOS pattern on early retesting.
- Timing of blood draw: A draw during a random pulse trough will underestimate average LH.
- Prolactin elevation: High prolactin suppresses GnRH and can mask the LH elevation. It's worth checking what happens to prolactin with PCOS if your LH appears normal but symptoms persist.
---
LH, the HPA Axis, and Adrenal Androgens
LH's story in PCOS doesn't end at the ovary. The hypothalamic-pituitary-adrenal (HPA) axis interacts significantly with the reproductive axis, and chronic stress — or HPA dysfunction — can amplify androgen excess through a separate route: adrenal DHEA-S production.
In some women, especially those reporting significant fatigue, mood instability, or a history of prolonged stress exposure, adrenal dysfunction sits alongside the ovarian androgen excess. The adrenal glands produce DHEA-S independently of LH, but elevated cortisol and disrupted cortisol rhythms affect GnRH pulsatility through central mechanisms. This overlap is why some clinicians evaluate the HPA axis alongside reproductive hormones in complex PCOS presentations. For a deeper look at HPA axis dysfunction and its downstream effects, this overview of adrenal support and cortisol covers the mechanisms in detail.
This does not mean every woman with PCOS has adrenal insufficiency — it means the systems are not isolated, and treating only the ovarian component may leave the picture incomplete.
---
AMH and LH: Parallel Markers of Follicular Disruption
Anti-Müllerian hormone (AMH) is produced by small growing follicles and is often dramatically elevated in PCOS — sometimes three to four times the upper limit of normal. AMH and LH track different aspects of the same underlying problem: AMH reflects follicular accumulation, while LH reflects the hormonal driver that prevents those follicles from maturing.
Research has shown that AMH itself may amplify GnRH pulse frequency, creating a feedback loop that keeps LH elevated (Cimino et al., Nature Communications 2016; PMID: 27503895). This means AMH isn't just a biomarker of PCOS severity — it may be mechanistically contributing to the LH excess. Understanding what happens to AMH with PCOS alongside LH helps build a more complete hormonal picture.
---
Can Nutrition and Supplements Influence LH in PCOS?
Direct, high-quality randomized trials specifically targeting LH normalization through supplements are limited, but several nutrients have demonstrated effects on the upstream drivers of elevated LH — particularly insulin resistance, androgen excess, and GnRH pulse dysregulation.
Inositol (Myo-inositol and D-chiro-inositol): Multiple trials have shown that inositol supplementation reduces LH and testosterone in women with PCOS while improving FSH signaling. A systematic review found that myo-inositol at 4g/day significantly lowered LH:FSH ratios over 12 to 24 weeks (Unfer et al., Gynecological Endocrinology 2012; PMID: 22296306). The mechanism likely operates through improved insulin signaling in ovarian tissue.
Omega-3 fatty acids: Anti-inflammatory and insulin-sensitizing effects of EPA and DHA may reduce the hyperinsulinemia that drives androgen excess. Evidence on direct LH reduction from omega-3 in PCOS is less robust, but the downstream androgen reduction is documented. See does omega-3 help with PCOS for a detailed breakdown of the evidence.
Vitamin D: Vitamin D receptors are present on pituitary and hypothalamic tissue, and deficiency has been associated with more pronounced LH:FSH imbalance in PCOS cohorts. Supplementation studies report improvements in menstrual regularity and ovulation rates, though effects on LH specifically vary by baseline deficiency status. The article on vitamin D and PCOS covers the clinical evidence in depth.
Zinc: Zinc is involved in GnRH receptor function and modulates pituitary sensitivity. Small trials in PCOS populations have reported reductions in free androgen index with zinc supplementation, with some evidence of LH modulation. The full picture is reviewed in does zinc help with PCOS.
Ashwagandha (KSM-66): While not a direct LH modulator, ashwagandha's well-documented cortisol-lowering effects — with KSM-66 at 600mg/day reducing cortisol by approximately 27.9% in a double-blind trial (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798) — may reduce HPA-driven contributions to androgen excess in women where stress intersects with PCOS.
---
What This Means for Your Formula
LH elevation in PCOS is a downstream consequence of multiple converging inputs: rapid GnRH pulsatility, insulin resistance, elevated AMH, and, in some cases, HPA axis dysregulation. Addressing a single pathway in isolation rarely produces sustained improvement.
Ones uses bloodwork and health data to identify which of these inputs is most active in your specific profile. For women showing insulin-related androgen excess alongside an elevated LH:FSH ratio, the formula may include Omega-3 (EPA/DHA) at clinically meaningful doses to target systemic inflammation and insulin sensitivity — the same mechanism studied in PCOS omega-3 trials. Where vitamin D deficiency is present — which is common in PCOS populations — Vitamin D3 paired with MK-7 K2 is included to support hormonal signaling at the pituitary level. In cases where adrenal androgen contribution or chronic stress is flagged, Ashwagandha KSM-66 at 600mg addresses cortisol-mediated upstream disruption.
The formula is not a standard PCOS stack — it's calibrated to your findings. The AI evaluates which markers are actually out of range, and the capsule plan (6 or 9 capsules daily, selected based on your data) reflects the number of active targets, not a default protocol.
---
Key Takeaways
- In most women with PCOS, LH is chronically elevated relative to FSH — often at a ratio of 2:1 or higher — due to accelerated GnRH pulse frequency from the hypothalamus.
- Elevated LH drives excess androgen production in ovarian theca cells, stalling follicular maturation and producing the polycystic appearance and androgen symptoms.
- Not all women with PCOS show elevated LH on testing — obesity, oral contraceptive history, and blood draw timing can all mask the pattern.
- Insulin resistance feeds androgen excess independently of LH, making metabolic markers like fasting insulin equally important to evaluate alongside the LH:FSH ratio.
- AMH may actively amplify GnRH pulsatility, creating a feedback loop that sustains elevated LH — meaning AMH is not just a passive biomarker.
- Nutrients including inositol, omega-3 fatty acids, vitamin D, and zinc have documented effects on upstream drivers of LH elevation, with the strongest evidence for inositol directly lowering the LH:FSH ratio.